CoChat

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry

Open access
Younossi, Zobair M., Yilmaz, Yusuf, Yu, Ming-Lung, Wai-Sun Wong, Vincent, Fernandez, Marlen Castellanos, Isakov, Vasily A., Duseja, Ajay K., Mendez-Sanchez, Nahum, Eguchi, Yuichiro, Bugianesi, Elisabetta, Burra, Patrizia, George, Jacob, Fan, Jian-Gao, Papatheodoridis, George V., Chan, Wah Kheong, Alswat, Khalid, Saeed, Hamid S., Singal, Ashwani K., Romero-Gomez, Manuel, Gordon, Stuart C., Roberts, Stuart K., El Kassas, Mohamed, Kugelmas, Marcelo, Ong, Janus P., Alqahtani, Saleh, Ziayee, Mariam, Lam, Brian, Younossi, Issah, Racila, Andrei, Henry, Linda, Stepanova, Maria · 2022 · Clinical Gastroenterology and Hepatology
Cited by 107

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

BACKGROUND Globally, nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. We assessed clinical presentation and patient-reported outcomes (PROs) among NAFLD patients from different countries. METHODS Clinical, laboratory and PRO data (CLDQ-NASH, FACIT-F, WPAI) were collected from NAFLD patients seen in real-world practices and enrolled in the Global NAFLD/NASH Registry (GNR) encompassing 18 countries in 6 Global Burden of Disease (GBD) super-regions. RESULTS Across the GBD super-regions, NAFLD patients (n=5691) were oldest in Latin America and Eastern Europe, youngest in South Asia. Most males were enrolled in Southeast and South Asia sites. Latin America and South Asia had the highest employment rates (>60%). Rates of cirrhosis varied (12-21%); highest in North Africa/Middle East and Eastern Europe. Rates of metabolic syndrome components varied: 20-25% in South Asia, 60-80% in Eastern Europe. CLDQ-NASH and FACIT-F PRO scores were lower in NAFLD patients than general population norms (all p<0.001). Across the super-regions, the lowest PRO scores were seen in Eastern Europe and North Africa/Middle East. In multivariate analysis adjusted for enrollment region, independent predictors of lower PRO scores included younger age, female gender, and non-hepatic comorbidities including fatigue (p<0.01). Patients whose fatigue scores improved over time experienced a substantial PRO improvement. Nearly 8% of GNR patients had lean BMI with fewer metabolic syndrome components, fewer comorbidities, less cirrhosis, and significantly better PRO scores (p<0.01). CONCLUSION NAFLD patients seen in real-world practices in different countries experience high comorbidity burden and impaired quality of life. Future research using global data will enable more precise management and treatment strategies for these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2021.11.004

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 107

Metadata

Authors
Younossi, Z. M., Yilmaz, Y., Yu, M.-L., Wai-Sun Wong, V., Fernandez, M. C., Isakov, V. A., Duseja, A. K., Mendez-Sanchez, N., Eguchi, Y., Bugianesi, E., Burra, P., George, J., Fan, J.-G., Papatheodoridis, G. V., Chan, W. K., Alswat, K., Saeed, H. S., Singal, A. K., Romero-Gomez, M., Gordon, S. C., Roberts, S. K., El Kassas, M., Kugelmas, M., Ong, J. P., Alqahtani, S., Ziayee, M., Lam, B., Younossi, I., Racila, A., Henry, L., & Stepanova, M.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2022-10
Volume
20
Issue
10
Pages
2296-2306.e6
ISSN
1542-3565 (ISSN-L)
OpenAlex
W3214123755
Cited by
107
References
6
FWCI
10.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.